NANOSTRING TECHNOLOGIES INC (NSTG) Fundamental Analysis & Valuation
NASDAQ:NSTG • US63009R1095
Current stock price
0.1053 USD
-0.06 (-37.43%)
At close:
0.1051 USD
0 (-0.19%)
After Hours:
This NSTG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NSTG Profitability Analysis
1.1 Basic Checks
- NSTG had negative earnings in the past year.
- NSTG had a negative operating cash flow in the past year.
1.2 Ratios
- With a Return On Assets value of -60.59%, NSTG is not doing good in the industry: 91.80% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.59% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-29.8%
ROA(5y)-31.5%
ROE(3y)-149.76%
ROE(5y)-139.62%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 35.72%, NSTG is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of NSTG has declined.
- The Profit Margin and Operating Margin are not available for NSTG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.72% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.22%
GM growth 5Y-7.64%
2. NSTG Health Analysis
2.1 Basic Checks
- NSTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NSTG has more shares outstanding
- NSTG has a worse debt/assets ratio than last year.
2.2 Solvency
- NSTG has an Altman-Z score of -5.51. This is a bad value and indicates that NSTG is not financially healthy and even has some risk of bankruptcy.
- NSTG has a Altman-Z score of -5.51. This is amonst the worse of the industry: NSTG underperforms 81.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.51 |
ROIC/WACCN/A
WACC2.41%
2.3 Liquidity
- NSTG has a Current Ratio of 2.73. This indicates that NSTG is financially healthy and has no problem in meeting its short term obligations.
- NSTG has a Current ratio (2.73) which is comparable to the rest of the industry.
- NSTG has a Quick Ratio of 2.02. This indicates that NSTG is financially healthy and has no problem in meeting its short term obligations.
- NSTG has a Quick ratio of 2.02. This is comparable to the rest of the industry: NSTG outperforms 47.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.02 |
3. NSTG Growth Analysis
3.1 Past
- NSTG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.42%.
- Looking at the last year, NSTG shows a very strong growth in Revenue. The Revenue has grown by 20.09%.
- NSTG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.07% yearly.
EPS 1Y (TTM)-12.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.27%
Revenue 1Y (TTM)20.09%
Revenue growth 3Y0.45%
Revenue growth 5Y2.07%
Sales Q2Q%62.8%
3.2 Future
- The Earnings Per Share is expected to grow by 15.87% on average over the next years. This is quite good.
- The Revenue is expected to grow by 22.47% on average over the next years. This is a very strong growth
EPS Next Y4.9%
EPS Next 2Y22.45%
EPS Next 3Y18.14%
EPS Next 5Y15.87%
Revenue Next Year40.02%
Revenue Next 2Y26.22%
Revenue Next 3Y23.31%
Revenue Next 5Y22.47%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. NSTG Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for NSTG. In the last year negative earnings were reported.
- Also next year NSTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- NSTG's earnings are expected to grow with 18.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.45%
EPS Next 3Y18.14%
5. NSTG Dividend Analysis
5.1 Amount
- NSTG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NSTG Fundamentals: All Metrics, Ratios and Statistics
0.1053
-0.06 (-37.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-06 2023-11-06/amc
Earnings (Next)02-27 2024-02-27/amc
Inst Owners0%
Inst Owner Change-97.01%
Ins Owners17.53%
Ins Owner Change0%
Market Cap5.07M
Revenue(TTM)162.48M
Net Income(TTM)-166.43M
Analysts76.92
Price Target2.07 (1865.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.73%
Min EPS beat(2)-33.62%
Max EPS beat(2)-31.85%
EPS beat(4)0
Avg EPS beat(4)-36.24%
Min EPS beat(4)-61.05%
Max EPS beat(4)-18.46%
EPS beat(8)0
Avg EPS beat(8)-33.39%
EPS beat(12)0
Avg EPS beat(12)-25.98%
EPS beat(16)1
Avg EPS beat(16)-25.37%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.8%
Revenue beat(4)3
Avg Revenue beat(4)1.93%
Min Revenue beat(4)-0.12%
Max Revenue beat(4)5.95%
Revenue beat(8)4
Avg Revenue beat(8)-2.76%
Revenue beat(12)7
Avg Revenue beat(12)-1.56%
Revenue beat(16)11
Avg Revenue beat(16)2.19%
PT rev (1m)0%
PT rev (3m)-78.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.53
EYN/A
EPS(NY)-1.73
Fwd EYN/A
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)-2.39
OCFYN/A
SpS3.38
BVpS-1.05
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.59% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.72% | ||
| FCFM | N/A |
ROA(3y)-29.8%
ROA(5y)-31.5%
ROE(3y)-149.76%
ROE(5y)-139.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.22%
GM growth 5Y-7.64%
F-Score2
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 144.24% | ||
| Cap/Sales | 12.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | -5.51 |
F-Score2
WACC2.41%
ROIC/WACCN/A
Cap/Depr(3y)187.15%
Cap/Depr(5y)166.43%
Cap/Sales(3y)10.15%
Cap/Sales(5y)8.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.27%
EPS Next Y4.9%
EPS Next 2Y22.45%
EPS Next 3Y18.14%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.09%
Revenue growth 3Y0.45%
Revenue growth 5Y2.07%
Sales Q2Q%62.8%
Revenue Next Year40.02%
Revenue Next 2Y26.22%
Revenue Next 3Y23.31%
Revenue Next 5Y22.47%
EBIT growth 1Y-18.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.66%
EBIT Next 3Y23.81%
EBIT Next 5Y19.06%
FCF growth 1Y-50.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.03%
OCF growth 3YN/A
OCF growth 5YN/A
NANOSTRING TECHNOLOGIES INC / NSTG Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NANOSTRING TECHNOLOGIES INC (NSTG) stock?
ChartMill assigns a fundamental rating of 2 / 10 to NSTG.
What is the valuation status of NANOSTRING TECHNOLOGIES INC (NSTG) stock?
ChartMill assigns a valuation rating of 0 / 10 to NANOSTRING TECHNOLOGIES INC (NSTG). This can be considered as Overvalued.
What is the profitability of NSTG stock?
NANOSTRING TECHNOLOGIES INC (NSTG) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for NSTG stock?
The Earnings per Share (EPS) of NANOSTRING TECHNOLOGIES INC (NSTG) is expected to grow by 4.9% in the next year.